Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014

OBJECTIVE: The objective of this study was to describe healthcare resource use and cost development in Sweden during 2006–2014 in a type 2 diabetes (T2D) population receiving glucose-lowering drugs (GLDs). METHODS: In- and outpatient healthcare resource use and costs were extracted from mandatory na...

Descripción completa

Detalles Bibliográficos
Autores principales: Nathanson, David, Sabale, Ugne, Eriksson, Jan W., Nyström, Thomas, Norhammar, Anna, Olsson, Urban, Bodegård, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249189/
https://www.ncbi.nlm.nih.gov/pubmed/29623637
http://dx.doi.org/10.1007/s41669-017-0063-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249189/
https://www.ncbi.nlm.nih.gov/pubmed/29623637
http://dx.doi.org/10.1007/s41669-017-0063-y

Ejemplares similares